ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 47 filers reported holding ARALEZ PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $23,000 | 0.0% | 15,268 | 0.0% | 0.00% | – |
Q1 2018 | $23,000 | -11.5% | 15,268 | -17.3% | 0.00% | – |
Q4 2017 | $26,000 | -25.7% | 18,468 | +21.0% | 0.00% | – |
Q3 2017 | $35,000 | +66.7% | 15,268 | 0.0% | 0.00% | – |
Q2 2017 | $21,000 | -36.4% | 15,268 | 0.0% | 0.00% | -100.0% |
Q1 2017 | $33,000 | -50.7% | 15,268 | -0.0% | 0.00% | 0.0% |
Q4 2016 | $67,000 | -34.3% | 15,274 | -27.8% | 0.00% | -50.0% |
Q3 2016 | $102,000 | +104.0% | 21,152 | +38.5% | 0.00% | +100.0% |
Q2 2016 | $50,000 | – | 15,274 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 2,680,140 | $11,820,000 | 7.87% |
Tiger Legatus Capital Management, LLC | 1,985,000 | $8,754,000 | 3.24% |
ARMISTICE CAPITAL, LLC | 2,836,000 | $12,507,000 | 2.96% |
Healthcare Value Capital, LLC | 575,000 | $2,536,000 | 2.72% |
Broadfin Capital, LLC | 4,791,590 | $21,131,000 | 2.35% |
FNY Managed Accounts LLC | 73,983 | $326,265,000 | 2.19% |
Elk Creek Partners, LLC | 2,196,055 | $9,685,000 | 0.65% |
Bryn Mawr Capital Management, LLC | 107,492 | $474,000 | 0.48% |
Par Capital Management | 6,400,000 | $28,224,000 | 0.37% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,644,583 | $7,253,000 | 0.30% |